Adherence to anti-hypertensive treatment within a chronic disease management program: A longitudinal, retrospective study

Objective This study assessed pharmacological treatment adherence using the Morisky-Green Test and identified related variables. Method A longitudinal and retrospective study examined 283 patients with hypertension (62.5% women, 73.4 [10.9] years old) who were being monitored by a chronic disease management program for 17 months between 2011 and 2012. Nurses performed all the actions of the program, which consisted of advice via telephone and periodic home visits based on the risk stratification of the patients. Results A significant increase in treatment adherence (25.1% vs. 85.5%) and a decrease in blood pressure were observed (p<0.05). Patients with hypertension and chronic renal failure as well as those treated using angiotensin-converting enzyme inhibitors were the most adherent (p<0.05). Patients with hypertension who received angiotensin receptor blockers were less adherent (p<0.05). Conclusions Strategies such as nurse-performed chronic disease management can increase adherence to anti-hypertensive treatment and therefore contribute to the control of blood pressure, minimizing the morbidity profiles of patients with hypertension.

Independent Living Program, Fall 2006

A Day in the Life of Agnes.

Independent Living Program, Summer 2006

Iowa's Visually-Impaired and Blind Seniors Gain Confidence and Independence!

Independent Living Program, Spring 2006

The Iowa Department for the Blind partnered with The Lodge of Ashworth retirement community in West Des Moines to bring information to visually impaired residents, friends and family. The Lodge furnished refreshments, and the Department furnished the programming.

Independent Living Program, Winter 2006

LENORE'S STORY Lenore Barnes began losing vision in her early eighties due to macular degeneration. In her mid-eighties she quit driving and purchased a CCTV. Her vision continued to decrease, and while the CCTV remained helpful it was of diminishing benefit.

Independent Living Program, Vol. 2, 2007

The Iowa Department for the Blind is the state agency that serves Iowans with vision loss. Services are free, confidential and available statewide. "There are no limitations to what you can do with training and a positive attitude." (All quotes in this newsletter are from former training participants). At the Iowa Department for the Blind, we believe in a positive approach to blindness. Vision loss alone should not prevent anyone from being independent. For this reason, we offer a wide variety of opportunities to obtain the skills necessary for independence.

Independent Living Program, Spring 2005

Rehabilitation Teachers -- Who are they and what do they do? Blindness Techniques to assist, in everyday activities and upcoming events all in this issue.

A-1 Monthly Public Assistance Statistical Report Family Investment Program, December 2006

A-1 Monthly Public Assistance Statistical Report Family Investment Program.

A-1A Supplemental Security Income Program, December 2006

A-1A Supplemental Security Income Program, December 2006

F-1 Food Assistance Program State Summary, December 2006

F-1 Food Assistance Program State Summary, December 2006

A-1A Supplemental Security Income Program, January 2007

Supplemental Security Income Program, January 2007

A-1 Monthly Public Assistance Statistical Report Family Investment Program, January 2007

A-1 Monthly Public Assistance Statistical Report Family Investment Program for January 2007

F-1 Food Assistance Program State Summary, January 2007

The Food Assistance Monthly Participation Report is a monthly summary of Food Assistance program participation, Statewide and for each Iowa county. Breakouts are reported for participants also in the FIP program, those only receiving Food Assistance, and those that are receiving economic assistance under other programs (primarily Medicaid). This report may also be known as the F-1 Report.

The European dimension for the mouse genome mutagenesis program.

The European Mouse Mutagenesis Consortium is the European initiative contributing to the international effort on functional annotation of the mouse genome. Its objectives are to establish and integrate mutagenesis platforms, gene expression resources, phenotyping units, storage and distribution centers and bioinformatics resources. The combined efforts will accelerate our understanding of gene function and of human health and disease.